Insider Sale by Loeillot Olivier (Chief Executive Officer)
Trade Summary
6 days ago, Loeillot Olivier, serving as Chief Executive Officer at REPLIGEN CORP (RGEN), sold 3,035 shares at $165.90 per share, for a total transaction value of $503,506.50. Following this transaction, Loeillot Olivier now holds 48,369 shares of RGEN.
This sale represents a 5.90% decrease in Loeillot Olivier's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Friday, September 4, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, September 8, 2026 at 4:13 PM ET, 4 days after the trade was made.
REPLIGEN CORP operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$165.90
Quantity
3,035
Total Value
$503,506.50
Shares Owned
48,369
Trade Date
6 days ago
SEC Filing Date
at 4:13 PM ET
Filed 4 days after trade
Discussion